DUBLIN, June 9, 2023 /PRNewswire/ — The “Gene Amplification Technologies Market Report 2023-2033” report has been added to ResearchAndMarkets.com’s offering.
The Gene Amplification Technologies Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or expand their existing operations in a new region.
A Rise in Demand for Genetic Data Collecting to Identify and Map Every Gene in the Human Genome Is Causing the Global Market to Expand
Gene amplification is the differential expansion of a certain region of the genome relative to the rest. Most species appear to engage in this process, which has been demonstrated to take place in both somatic and germline cells. Gene Amplification can have positive such as growth or survival benefit or negative effects on the organism. It can be linked to normal developmental processes or occur as spontaneous genetic events. Somatic cell gene amplification in human malignancies has lately received substantial research. Proto-oncogene amplification may cause or contribute to the development of tumours. The amplified gene may occasionally serve as a viable target for cancer treatment. It mentions the growth of a certain DNA from a very little volume.
A rise in demand for genetic data collecting to identify and map every gene in the human genome is causing the global market to expand. The global market for gene amplification technology is being driven by the widespread acceptance of specific cancer therapies. Human Genome Projects continue to be the primary factor driving the market for gene amplification technology (HGP).
The Growing Adoption of Customised Medicine, and Expanding Research in Molecular Diagnostics and Genomics Are the Key Market Drivers
The arrival of fresh and cutting-edge products, the growing adoption of customised medicine, and expanding research in molecular diagnostics and genomics are the key market drivers. In the near future, it is projected that rising genomics investments by pharmaceutical and biotechnology businesses would significantly fuel the industry. The biotechnology industry has recently seen a considerable shift toward novel pharmaceuticals and therapies, medicines based on genome sequencing, and technological developments, which has fuelled market expansion. The commercial adoption of gene multiplication techniques has been affected by improvements in molecular diagnostic tools such as NGS, droplet digital PCR, and genome-wide sequencing with respect to reproducibility, accuracy, and timeframe. The industry for gene multiplication technology has also been boosted by international projects like the Africa Pathogen Genomics Initiative (Africa PGI).
What Questions Should You Ask before Buying a Market Research Report?
- How is the gene amplification technologies market evolving?
- What is driving and restraining the gene amplification technologies market?
- How will each gene amplification technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each gene amplification technologies submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading gene amplification technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the gene amplification technologies projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of gene amplification technologies projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the gene amplification technologies market?
- Where is the gene amplification technologies market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the gene amplification technologies market today, and over the next 10 years:
- The 425-page report provides 176 tables and 190 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them – NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the gene amplification technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce back. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting for 2033, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising gene amplification technologies prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Market Segment by Sample Type
- Single Cell
- Formalin-Fixed & Paraffin-Embedded (FFPE)
Market Segment by End-User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Other End-Users
Market Segment by Business Type
- Gene Amplification Kits & Reagents
- Gene Amplification Instruments
- Gene Amplification Services
- Gene Amplification Ancillaries
Market Segment by Application
- Hybridization Application
- Whole Genome Amplification
- Exome Sequencing Amplification
- SNP Genotyping Arrays
- Array CGH
Market Segment by Technology
- PCR-based Amplification
- Loop-mediated Isothermal Amplification
- Nucleic Acid Sequence Based Amplification
- Strand Displacement Amplification
- Multiple Displacement Amplification
- Other Technology
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
Europe
- Germany
- Spain
- United Kingdom
- France
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
The report also includes profiles and for some of the leading companies in the Gene Amplification Technologies Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Overall world revenue for Gene Amplification Technologies Market, 2023 to 2033 in terms of value the market will surpass US$4,853 million in 2023, this work calculates. We predict strong revenue growth through to 2033. this work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Gene Amplification Technologies Market, 2023 to 2033 report help you?
In summary, this 420+ page report provides you with the following knowledge:
- Revenue forecasts to 2033 for Gene Amplification Technologies Market, 2023 to 2033 Market, with forecasts for application, technology, sample type, business type, end-user and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for four regional and 20 key national markets – See forecasts for the Gene Amplification Technologies Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Gene Amplification Technologies Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.
Companies Mentioned:
- 4BASEBIO AG
- Abbott Laboratories
- Agilent Technologies, Inc.
- Ambion Inc.
- Bayer Pharmaceutics AG
- Becton Dickinson and Co.
- Bio-Rad Laboratories
- Danaher Corporation
- Illumina Inc.
- LGC Group
- Merck KGaA
- MyBioSource
- Nanjing Vazyme Biotech Co.
- New England Biolabs
- PerkinElmer Inc.
- Promega Corporation
- Qiagen N.V.
- Silicon Biosystems
- Takara Bio Inc.
- Yikang Inc.
- 4D Molecular Therapeutics
- Abeona Therapeutics
- Actus Therapeutics
- Adrenas
- Adverum Biotechnologies
- Akouos
- Amicus Therapeutics
- Apollo Therapeutics
- Aruvant Sciences
- Aspa Therapeutics
- Audentes
- AVROBIO
- Axovant Sciences Ltd
- BioVec Pharma
- Brainvectis SAS
- Catalyst Biosciences
- CavoGene Lifesciences
- Copernicus Therapeutics
- CRISPR Therapeutics AG
- Editas Medicine
- Enzo Biochem
- Errant Gene Therapeutics
- Esteve Pharmaceuticals SA
- Excision BioTherapeutics
- Exonics Therapeutics
- Expression Therapeutics
- Fibrocell Science
- Freeline Therapeutics
- Gemini Therapeutics
- Generation Bio Corp.
- Genethon SA
- GenSight Biologics SA
- Gyroscope Therapeutics
- Hemera Biosciences
- Holostem Terapie Avanzate Srl
- Homology Medicines
- Horama SA
- Immusoft Corp.
- iTherapeutics Corp.
- IVERIC bio
- Krystal Biotech
- Lamellar Biomedical
- Logicbio Therapeutics
- Lysogene
- Lysogene SAS/ Sarepta Therapeutics
- MeiraGTx
- Milo Biotechnology
- Mustang Bio
- NanoScope Technologies
- NeuExcell Therapeutics
- Nightstar Therapeutics/
- Passage Bio
- Therapeutics
- PTC Therapeutics
- Renova Therapeutics
- Rocket Pharmaceuticals
- Rubius Therapeutics
- SanBio Co
- Tamid Bio
- Telocyte
- Temprian Therapeutics
- Tocagen
- Tolerion
- Ultragenyx Pharmaceutical
- ViroMed Co Ltd
- Vivet Therapeutics SAS
- Association of British Pharmaceutical Industry (ABPI)
- Central Drugs Standard Control Organization (CDSCO)
- Department of Health and Family Welfare
- Development and Reform Commission (NDRC)
- Food and Drug Administration (US FDA)
- Gene Therapy Net
- Indian Drug Manufacturer’s Association (IDMA)
- Informa UK Limited
- IntechOpen
- International Society of Pharmaceutical Engineering (IPSE)
- JOURNAL OF GENERAL VIROLOGY
- Korea Food and Drug Administration (KFDA)
- Korea Pharmaceutical Manufacturer’s Association (KPMA)
- Massachusetts Medical Society
- Medicines and Healthcare Products Regulatory Agency (MHRA)
- Medicines Manufacturing Industry Partnership (MMIP)
- Ministry of Health (MOH)
- Ministry of Health, Labor and Welfare (MHLW)
- Ministry of Industry and Information Technology (MIIT)
- National Center for Biotechnology Information
- Pan European Networks Ltd
- Pharma Manufacturing
- Pharmaceutical and Medical Devices Agency (PMDA)
- Pharmaceutical-Networking.com
- South Americaan Commission
- South Americaan Medicines Agency (EMA)
- The Alliance for Regenerative Medicine
- The Royal Society
- World Health Organization (WHO)
For more information about this report visit https://www.researchandmarkets.com/r/1hxhzr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
